Perspective Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Perspective Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q4 2023.
  • Perspective Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $30M, a 45.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $30M +$9.35M +45.4% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $20.6M Dec 31, 2022 10-K 2024-03-28
Q2 2022 $19.1M +$1.43M +8.09% Jun 30, 2022 10-K 2024-03-28
Q2 2021 $17.6M +$659K +3.88% Jun 30, 2021 10-KT 2023-05-01
Q2 2020 $17M +$739K +4.55% Jun 30, 2020 10-K 2021-09-27
Q2 2019 $16.2M +$1.23M +8.18% Jun 30, 2019 10-K 2020-09-25
Q2 2018 $15M -$7.7M -33.9% Jun 30, 2018 10-K 2019-09-27
Q2 2017 $22.7M +$2.12M +10.3% Jun 30, 2017 10-K 2018-09-26
Q2 2016 $20.6M +$1.68M +8.85% Jun 30, 2016 10-K 2017-09-28
Q2 2015 $18.9M +$1.39M +7.93% Jun 30, 2015 10-K 2016-09-09
Q2 2014 $17.5M +$1.74M +11% Jun 30, 2014 10-K 2015-09-14
Q2 2013 $15.8M +$1.26M +8.65% Jun 30, 2013 10-K 2014-09-29
Q2 2012 $14.5M +$1.47M +11.2% Jun 30, 2012 10-K 2013-09-30
Q2 2011 $13.1M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.